Zuochong Yu

644 total citations
17 papers, 502 citations indexed

About

Zuochong Yu is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Zuochong Yu has authored 17 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Biomedical Engineering and 4 papers in Oncology. Recurrent topics in Zuochong Yu's work include RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Cancer Cells and Metastasis (4 papers). Zuochong Yu is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Cancer Cells and Metastasis (4 papers). Zuochong Yu collaborates with scholars based in China and United States. Zuochong Yu's co-authors include Huaiwen Chen, Xinchao Zhang, Zhe Ge, Fangyi Chen, Xiaoxia Qi, Qingmin Zeng, Min Xiong, Yingying Zhang, Fei Zou and Jingkang Guo and has published in prestigious journals such as Composites Part B Engineering, Cell Death and Disease and Nano Today.

In The Last Decade

Zuochong Yu

17 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zuochong Yu China	10	258	182	133	102	63	17	502
Si Cheng China	15	261 1.0×	141 0.8×	121 0.9×	35 0.3×	28 0.4×	30	516
Xiumei Zhu China	13	240 0.9×	97 0.5×	169 1.3×	102 1.0×	16 0.3×	20	525
Haoyu Guo China	13	387 1.5×	182 1.0×	95 0.7×	56 0.5×	31 0.5×	27	659
Hye‐Eun Shim South Korea	13	342 1.3×	115 0.6×	75 0.6×	171 1.7×	76 1.2×	26	634
Asiri Ediriwickrema United States	12	238 0.9×	142 0.8×	119 0.9×	62 0.6×	15 0.2×	22	628
Yuanlong Xie China	17	325 1.3×	253 1.4×	154 1.2×	70 0.7×	21 0.3×	43	760
Shaobo Xue China	12	289 1.1×	136 0.7×	109 0.8×	100 1.0×	29 0.5×	20	664
Ziba Veisi Malekshahi Iran	12	293 1.1×	149 0.8×	162 1.2×	83 0.8×	14 0.2×	28	612
Tai‐Wei Zhang China	10	125 0.5×	247 1.4×	107 0.8×	26 0.3×	78 1.2×	19	493

Countries citing papers authored by Zuochong Yu

Since Specialization

Citations

This map shows the geographic impact of Zuochong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuochong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuochong Yu more than expected).

Fields of papers citing papers by Zuochong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuochong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuochong Yu. The network helps show where Zuochong Yu may publish in the future.

Co-authorship network of co-authors of Zuochong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuochong Yu. A scholar is included among the top collaborators of Zuochong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuochong Yu. Zuochong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Yu, Tinglin Zhang, Qiao Wen, et al.. (2025). Enhancing bone healing through immunological microenvironment modulation via a smart-responsive multifunctional therapeutic system. Composites Part B Engineering. 297. 112252–112252. 4 indexed citations

Lin, Zhidi, Xiao Lu, Guangyu Xu, et al.. (2025). The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration. Bone Research. 13(1). 72–72. 1 indexed citations

Li, Xinying, Zhenzhen Yan, Yuan Gao, et al.. (2025). Modulating autophagy in the tumor microenvironment with a salinomycin-loaded liposome hybrid nanovesicle system for tumor immunotherapy. Nano Today. 61. 102644–102644. 4 indexed citations

Wang, Yu, et al.. (2025). An injectable multifunctional nanocomposite hydrogel promotes vascularized bone regeneration by regulating macrophages. Journal of Nanobiotechnology. 23(1). 283–283. 7 indexed citations

Wang, Yu, et al.. (2024). Exploring the frontiers: The potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration. Materials Today Bio. 29. 101276–101276. 13 indexed citations

Wang, Yu, Xuan Zhou, Zhenzhen Yan, et al.. (2024). Innovative Biomaterials for Bone Tumor Treatment and Regeneration: Tackling Postoperative Challenges and Charting the Path Forward. Advanced Healthcare Materials. 13(16). e2304060–e2304060. 19 indexed citations

Wang, Yu, et al.. (2023). Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma. Journal of Nanobiotechnology. 21(1). 243–243. 27 indexed citations

Wang, Yu, et al.. (2023). EGFR-targeting peptide conjugated polymer–lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma. Journal of Cancer Research and Therapeutics. 19(6). 1544–1551. 3 indexed citations

Yu, Zuochong, et al.. (2022). Synergistic effect of growth factor receptor-bound protein 2/epidermal growth factor receptor dual-targeting peptide inhibitor and salinomycin on osteosarcoma. Journal of Cancer Research and Therapeutics. 18(2). 352–361. 3 indexed citations

10.

He, Yiqun, et al.. (2022). Exosomal let‐7f‐5p derived from mineralized osteoblasts promotes the angiogenesis of endothelial cells via the DUSP1/Erk1/2 signaling pathway. Journal of Tissue Engineering and Regenerative Medicine. 16(12). 1184–1195. 7 indexed citations

11.

Chen, Fangyi, Zhe Ge, Nan Li, et al.. (2022). TUDCA protects against tunicamycin‑induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress. Experimental and Therapeutic Medicine. 24(2). 509–509. 9 indexed citations

12.

Xie, Lin, Weibo Huang, Zhenhua Fang, et al.. (2019). CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis. Cell Death and Disease. 10(10). 751–751. 111 indexed citations

13.

Zhang, Xinchao, Fangyi Chen, Zhe Ge, et al.. (2019). Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells. Biomedicine & Pharmacotherapy. 111. 751–764. 50 indexed citations

14.

Chen, Fangyi, Xiaoxia Qi, Yanchao Chen, et al.. (2018). Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 2115–2127. 60 indexed citations

15.

Zeng, Yibin, Zuochong Yu, Yanni He, et al.. (2017). Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells. Acta Pharmacologica Sinica. 39(2). 261–274. 45 indexed citations

16.

Yu, Zuochong, Fangyi Chen, Xiaoxia Qi, et al.. (2017). Epidermal growth factor receptor aptamer‑conjugated polymer‑lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells. Experimental and Therapeutic Medicine. 15(2). 1247–1256. 37 indexed citations

17.

Yu, Zuochong, et al.. (2015). Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. International Journal of Nanomedicine. 10. 2537–2537. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact